Search

After the turbulence of credit crunch and recession, US venture capitalists regained some confidence in 2010. More money is becoming available for seed investments and start-ups, and the words Initial, Public and Offering are creeping back into the lexicon

Former Academic Enterprise Award (ACES) winner Novacem, a spin-out specialised in carbon negative cement, has secured a follow-on investment from the London Technology Fund.

It’s a year since Maire Geoghegan-Quinn stepped into her post, promising to be a woman of action. This week came the first concrete fruits of that pledge, with a pruning of R&D grant rules. But how much progress is the Commissioner for Research, Innovation and Science judged to have made elsewhere?

The European Commission has opened an official consultation procedure, in preparation of possible changes to public procurement rules.

University College London cancer vaccines spin-out BioVex has been bought by US biotech company Amgen in deal worth up to $1 billion.

The European Patent Organisation has received 10% more applications last year, and expects a further increase in 2011.

Off-label and unauthorised drugs are still being prescribed, according to a European survey on use of medicines for children.

Economic recovery would benefit from greener, private investment encouraging, government policies, according to an academic report.

More R&D investment is needed to increase the world's food supplies, concludes a UK Government Office for Science report.

Being first on the moon looks trifling next to all the things science is expected to do for us now

The Swiss Federal Institute of Technology in Lausanne has just opened the doors to a new national robotics research centre that aims to usher in a new era of robots, designed to do useful things in ordinary circumstances.